navigation: true

Recapitulation of Living Tissue Complexity

Innovative and Unique Bioink Formulations

Novel 3D Bioprinting Approach


Bioprinted Tissues-on-Demand


Morphodyne, a spinoff from École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, is developing 3D tissue and disease models based on its unique 3D bioprinting technology platform. Morphodyne combines proprietary bioink formulations with an innovative multimaterial printing approach to mimic tissue complexity. We aim to provide drug discovery and development pipelines with new assays able to better measure candidate efficacy and/or toxicity.

2D Cell-Based

Non-physiological conditions

3D Cell-Based

Lack of tissue complexity

Bioprinted Tissue Models

Recapitulation of tissue complexity

In Vivo

Stringent ethical issues

     Home | Contact

     © | Morphodyne SA - All rights reserved